BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 4408049)

  • 1. [Effect of a blood extract on plasma lipids, blood coagulation, fibrinolysis and platelet aggregation in experimental hypercholesterolemia of rabbits].
    Giarola P; Egge H; Gibelli A; Murawski U
    Arzneimittelforschung; 1974 Jun; 24(6):925-8. PubMed ID: 4408049
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P
    Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum lipids following experimental fibrinolysis].
    Suschke J; Kunze D; von Pilar CE; Krejci K
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):388-9. PubMed ID: 4270871
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of clofibrate in hypercholesterinemic rabbits and in arteriosclerotic subjects-modifications of platelet aggregation and fibrinolysis as related to lipidic fractions.
    Baldoni F; Egge H; Giarola P; Müller H; Cuttin S; Gibelli A; Zilliken F; de Nicola P
    New Istanbul Contrib Clin Sci; 1972 Dec; 10(3):135-8. PubMed ID: 4670445
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of debrisoquin, guanethidine and tyramine on platelet function and blood coagulation.
    Zbinden G; Tomlin S
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):153-69. PubMed ID: 5350778
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlations between hemostasis and lipidic patterns in hypercholesterinemic rabbits and arteriosclerotic patients under the treatment with di-isopropylammonium dichloroetanoate.
    de Nicola P; Giarola P; Egge H; Tammaro AE; Müller H; Bonaccorso O; Gibelli A
    Acta Univ Carol Med Monogr; 1972; 53():417-20. PubMed ID: 4670748
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic effects of thrombolytic therapy].
    Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
    [No Abstract]   [Full Text] [Related]  

  • 8. Modifications of bleeding time and intensity of prothrombin consumption and of fibrinolysis in rats after administration of platelet extracts alone and with antifibrinolytic agents.
    De Nicola P; Lüscher EF; Soardi F; Gibelli A; Cipolli PL
    Farmaco Sci; 1967 Aug; 22(8):627-40. PubMed ID: 6077137
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinolytic therapy of arteriosclerosis. Influence on hemocoagulation of a total arterial wall extract for oral use].
    Guglielmi G; Barlattani M; Garbagnati N; Iaschi P; Ciavarelli F
    Clin Ter; 1969 Sep; 50(6):527-36. PubMed ID: 5406050
    [No Abstract]   [Full Text] [Related]  

  • 10. Free fatty acids (FFA)--blood clotting, fibrinolysis and platelet function.
    Korsan-Bengtsen K; Holm T
    Scand J Haematol; 1974; 13(1):64-71. PubMed ID: 4413510
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of Atromid-S on thrombogenic factors].
    Cotton RC
    Minerva Med; 1971 Sep; 62(72):3466-8. PubMed ID: 5097218
    [No Abstract]   [Full Text] [Related]  

  • 12. -Pyridylcarbinol in experimental hypercholesterinemia of the rabbit. Study of lipidic fractions and of the mechanisms of hemostasis.
    Giarola P; Egge H; Gibelli A; Müller J
    Farmaco Sci; 1972 Nov; 27(11):1018-23. PubMed ID: 4647185
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-benzal-butyric acid, a new anti-adhesive drug.
    Mannucci PM; Maggi CA; Gioventu M; Marchi E; Terruzzi AB
    Acta Univ Carol Med Monogr; 1972; 53():409-12. PubMed ID: 4670746
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of stachydrine alkaloid on the blood coagulation system].
    Mansurov MM
    Farmakol Toksikol; 1972; 35(6):715-7. PubMed ID: 4651807
    [No Abstract]   [Full Text] [Related]  

  • 15. Short-term effects of fluvastatin, a hydroxylmethylglutaryl-coenzyme A reductase inhibitor, on coagulation and the fibrinolytic system in patients with hypercholesterolemia.
    Saito M; Asakura H; Morishita E; Yamazaki M; Matsuda T
    Int J Hematol; 1999 Jun; 69(4):274-6. PubMed ID: 10407589
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of various drugs on platelet aggregation and liberation of platelet factor 4 (anti-heparin factor)].
    Farbiszewski R; Niewiarowski S; Poplawski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):470-6. PubMed ID: 4193163
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of drugs on blood platelet characteristics].
    Zbinden G
    Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of pyridinolcarbamate (anginin) on blood coagulation, fibrinolysis and thrombocytes].
    Goossens N
    Thromb Diath Haemorrh Suppl; 1973; 55():273-84. PubMed ID: 4804076
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of chronic administration of lathyrogen (beta-aminopropionitrile) on blood clotting and fibrinolytic system in rabbits.
    Bańkowski E; Worowski K
    Thromb Diath Haemorrh; 1969 Nov; 22(2):372-6. PubMed ID: 5380956
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged plasma clotting time and decreased fibrinolysis after long term treatment with alpha-tocopherol.
    Korsan-Bengtsen K; Elmfeldt D; Holm T
    Thromb Diath Haemorrh; 1974 Jun; 31(3):505-12. PubMed ID: 4422949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.